Renal angiomyolipoma

Renal angiomyolipomas (AML) are a type of benign renal neoplasms encountered both sporadically and as part of a phakomatosis, most commonly tuberous sclerosis. They are considered one of a number of tumours with perivascular epithelioid cellular differentiation (PEComas) and are composed of vascular, smooth muscle and fat elements. They can spontaneously haemorrhage, which may be fatal. AMLs usually have characteristic radiographic appearances. 

Angiomyolipomas are the most common benign solid renal lesion and also the most common fat-containing lesions of the kidneys. The majority of angiomyolipomas are sporadic (80%) and are typically identified in adults (mean age of presentation 43 years), with a female predilection (F:M of 2-4:1) 7,9

The remaining 20% are seen in association with phakomatoses, the vast majority in the setting of tuberous sclerosis (80% of them get AML) although they have also been described in the setting of von Hippel-Lindau syndrome (vHL) and neurofibromatosis type 1 (NF1) 5,7. In these cases, they present earlier (usually identified by the age of 10 years), are larger, and are far more numerous. They are more likely to be fat-poor which accounts for their earlier presentation 2,6,7. They have also been associated with lymphangioleiomyomatosis (LAM) 20.

Angiomyolipomas are often found incidentally when the kidneys are imaged for other reasons, or as part of screening in patients with tuberous sclerosis. 

Symptomatic presentation is most frequently with spontaneous retroperitoneal haemorrhage; the risk of bleeding is proportional to the size of the lesion (>4 cm diameter). Shock due to severe haemorrhage from rupture is described as Wunderlich syndrome 4,5,7.

Patients may present with numerous other symptoms and signs 2, e.g. palpable mass, flank pain, urinary tract infectionshaematuria, renal failure, or hypertension 3.

Angiomyolipomas are members of the perivascular epithelioid cells tumour group (PEComas) and are composed of variable amounts of three components; blood vessels (-angio), plump spindle cells (-myo) and adipose tissue (-lipo).

Almost all classic angiomyolipomas are benign but they do have the risk of rupture with bleeding or secondary damage/destruction of surrounding structures as they grow. 

Two histological types have been described

  • typical (triphasic)
  • atypical (monophasic or epithelioid)

A special variant called an epithelioid angiomyolipoma is composed of more plump, epithelial-looking cells, often with nuclear atypia, that have a described risk of malignant behaviour. This variant, unlike conventional AMLs, may mimic renal cell carcinoma 10. Metastases have also been described 9

The cornerstone of diagnosis on all modalities is the demonstration of macroscopic fat, however in the setting of haemorrhage, or when lesions happen to contain little fat, it may be difficult to distinguish an angiomyolipoma from a renal cell carcinoma.

In tuberous sclerosis, the lesions are larger than isolated AML and often multiple and bilateral. 

  • tend to appear as hyperechoic lesions on ultrasound, located in the cortex and with posterior acoustic shadowing
  • in the setting of tuberous sclerosis, they may be so numerous that the entire kidney is affected, appearing echogenic with the loss of normal corticomedullary differentiation 7
  • contrast-enhanced ultrasound 12
    • tend to enhance peripherally
    • decreased central enhancement, compared with normal cortex

Most lesions involve the cortex and demonstrate macroscopic fat (less than -20 HU). When small, volume averaging may make differentiation from a small cyst difficult. It is essential to remember that rarely renal cell carcinomas (RCC) may have macroscopic fat components and as such the presence of fat is strongly indicative of an angiomyolipoma, but not pathognomonic.

It is important to realise that ~5% of angiomyolipomas are fat-poor 15. This is especially the case in the setting of tuberous sclerosis, where up to a third do not demonstrate macroscopic fat on CT 6. Absence of ossification/calcification on imaging is in favour of AML ref.

MRI is excellent at evaluating fat-containing lesions, and two main sets of sequences are employed. Firstly, fat-saturated techniques demonstrate high signal intensity on non-fat-saturated sequences and loss of signal following fat saturation. 

The second method is to use in-phase and out-of-phase imaging, which generates India ink artifact at the interface between fat and non-fat components. This can occur either at the interface between the angiomyolipoma and surrounding kidney or between fat and non-fat components of the mass 8. Chemical shift signal intensity loss, along with other features, may suggest a fat-poor AML 15

Angiomyolipomas are hypervascular lesions demonstrating often characteristic features:

  • arterial phase: a sharply marginated hypervascular mass with a dense early arterial network, and tortuous vessels giving the "sunburst" appearance
  • venous phase: whorled "onion peel" appearance of peripheral vessels
  • micro- or macro-aneurysms 2
  • absent arteriovenous shunting

Angiomyolipomas found incidentally usually require no therapy (when small), although follow-up is recommended to assess for growth. Small solitary AMLs (<20 mm) probably do not require follow-up due to their slow growth 13

Larger AMLs, or those that have been symptomatic, can be electively embolised and/or resected with a partial nephrectomy.

The traditional convention is that intervention is considered when an angiomyolipoma reaches 40 mm in size 18.

Lesions that present with retroperitoneal haemorrhage often require emergency embolisation as a life-saving measure.

mTOR inhibitors (e.g. everolimus) have been shown to significantly decrease AML size and may help to preserve renal function in tuberous sclerosis patients.

When an AML has typical appearances there is essentially no differential. If atypical, especially when fat-poor, other lesions to consider include:

Article information

rID: 899
System: Urogenital
Synonyms or Alternate Spellings:
  • Renal angiomyolipoma (AML)
  • Renal AML
  • Renal angiomyolipomas
  • Renal angiomyolipomata
  • Angiomyolipomas of the kidney

ADVERTISEMENT: Supporters see fewer/no ads

Cases and figures

  • Figure 1: gross pathology - renal angiomyolipoma
    Drag here to reorder.
  • Case 1
    Drag here to reorder.
  • Figure 2: histopathology - renal angiomyolipima
    Drag here to reorder.
  • Case 2: with complicating haemorrhage
    Drag here to reorder.
  • Case 3
    Drag here to reorder.
  • Case 4: with background tuberous sclerosis
    Drag here to reorder.
  • Case 5: presenting with the Wunderlich syndrome
    Drag here to reorder.
  • Case 6
    Drag here to reorder.
  • Case 7
    Drag here to reorder.
  • Case 8: showing feeder vessel prior to embolisation
    Drag here to reorder.
  • Case 9: very large lesion
    Drag here to reorder.
  • Case 10: large
    Drag here to reorder.
  • Fatty and vascula...
    Case 11: giant renal angiomyolipoma
    Drag here to reorder.
  • Case 12
    Drag here to reorder.
  • Case 13: with Wunderlich syndrome
    Drag here to reorder.
  • Case 14
    Drag here to reorder.
  • Case 15: with tuberous sclerosis
    Drag here to reorder.
  • Case 16
    Drag here to reorder.
  • Case 17: with tuberous sclerosis
    Drag here to reorder.
  • Case 18: with acute haemorrhage
    Drag here to reorder.
  • Case 19: haemorrhagic renal angiomyolipoma
    Drag here to reorder.
  • Case 20
    Drag here to reorder.
  • Case 21
    Drag here to reorder.
  • Case 22
    Drag here to reorder.
  • Case 23
    Drag here to reorder.
  • Case 24
    Drag here to reorder.
  • Case 25
    Drag here to reorder.
  • Case 26
    Drag here to reorder.
  • Case 27
    Drag here to reorder.
  • Updating… Please wait.

     Unable to process the form. Check for errors and try again.

     Thank you for updating your details.